medigraphic.com
ISSN 0210-5187 (Digital)

2012, Número 5

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2012; 40 (5)


Implantes cosméticos en Dermatología: características y efectos adversos

Molina-Ruiz AM, Requena L

Idioma: Español
Referencias bibliográficas: 77
Paginas: 131-146
Archivo PDF: 278.51 Kb.


RESUMEN

En este artículo se exponen los materiales de relleno más frecuentemente empleados en dermocosmética, los efectos secundarios más frecuentes, así como las características histopatológicas y ecográficas que permiten reconocer el tipo de relleno que se ha empleado.
Los materiales de relleno son utilizados como tratamiento cosmético destinado al aumento de tejidos blandos. Todos los materiales de relleno pueden producir reacciones adversas. En función de su duración en los tejidos, se clasifican en reabsorbibles y permanentes. Las sustancias reabsorbibles pueden generar efectos adversos graves pero suelen desaparecer de forma espontánea en pocos meses. Sin embargo, los materiales semipermanentes y los permanentes pueden producir complicaciones graves irreversibles o con escasa tendencia a la mejoría. Estos efectos adversos pueden aparecer años después del tratamiento, cuando muchos pacientes no recuerdan qué producto se usó y cuando las opciones terapéuticas suelen ser escasas y poco efectivas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Negrín-Díaz ML, Vásquez L, Sardi J, Camejo O. Reacciones adversas a materiales de relleno. Presentación de una serie de casos y revisión de la literatura. Dermatol Venez 2009; 47: 14-29.

  2. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27: 354-66.

  3. Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg 2004; 23: 214-7.

  4. Pimentel VN, Capote A, Santos E, Sánchez M. Efectos indeseables de los materiales de relleno. Monogr Dermatol 2011; 24: 244-8.

  5. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64: 1-34.

  6. Alfageme-Roldán F. Aplicaciones prácticas de la ecografía cutánea. Piel 2012; 27: 204-9.

  7. Wortsman X, Wortsman J, Orlandi C, Cardenas G, Sazunic I, Jemec GB. Ultrasound detection and identification of cosmetic fillers in the skin. J Eur Acad Dermatol Venereol 2012; 26: 292-301.

  8. Robinson JK, Hanke CW. Injectable collagen implant: Histopathologic identification and longevity of correction. J Dermatol Surg Oncol 1985; 11: 124-30.

  9. Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg 1977; 60: 389-405.

  10. Wallace DG, McPherson JJ, Ellingsworth LE. Injectable collagen for tissue augmentation. En: Nimni ME (ed) : Collagen, Vol III, Biotechnology. Boca Raton, FL, CRC Press, 1988, pp 117-44.

  11. Castrow II FF, Krull EA. Injectable collagen implant –updated. J Am Acad Dermatol 1983; 9: 889-93.

  12. DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987; 79: 581-94.

  13. Baumann L, Kaufman J, Saghari S. Collagen fillers. Dermatol Ther 2006; 19: 134-40.

  14. Bauman L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg 2004; 20: 125-8.

  15. Sclafani A, Romo T, Jacono AA, McCormick SA, Cocker R, Parker A. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation: clinical observations and histologic findings. Arch Facial Plast Surg 2000; 2: 130-6.

  16. Fagien S. Facial soft-tissue augmentation with injectable autologous and allogenic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg 2000; 105: 362-73.

  17. Ackerman AB, Guo Y, Vitale P. Clues to Diagnosis in Dermatopathology II. Chicago, ASCP Press, 1992, p. 385-8.

  18. Kligman AM, Armstrong RC. Histologic response to intradermal Zyderm and Zyplast (glutaraldehyde cross-linked) collagen in humans. J Dermatol Surg Oncol 1986; 12: 351-7.

  19. Burke KE, Naughton G, Cassai NA. Histological, immunological and electron microscopic study of bovine collagen implants in the human. Ann Plast Surg 1985; 14: 515-22.

  20. Stegman S, Chu S, Armstrong R. Adverse reactions to bovine collagen implant: clinical and histologic features. J Dermatol Surg Oncol 1988; 14: 39-48.

  21. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 1989; 15: 301-3.

  22. Rapaport MJ. Granuloma annulare caused by injectable collagen. Arch Dermatol 1984; 120: 837-8.

  23. García-Domingo MI, Alijotas Rey J, Cistero- Bahima A, Treserra F, Enrique E. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Invest Allergol Clin Immunol 2000; 10: 107-9.

  24. McGrew RN, Wilson RS, Havener WH. Sudden blindness secondary to injection of common drugs in the head and neck. Part 1: Clinical experiences. Otolaryngology 1978; 86: 147-51.

  25. Douglas RS, Donsoff I, Cook T, Shorr N. Collagen fillers in facial aesthetic surgery. Facial Plast Surg 2004; 20: 117-23.

  26. Sclafani A, Romo T, Jacono AA, McCormick SA, Cocker R, Parker A. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation: clinical observations and histologic findings. Arch Facial Plast Surg 2000; 2: 130-6.

  27. Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporine. Dermatol Surg 1999; 25: 247-9.

  28. Moody BR, Sengelmann RD. Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 2001; 27: 789-91.

  29. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, Voorhees JJ. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photo damaged human skin. Arch Dermatol 2007; 143; 155-63.

  30. Asín-Llorca M, Elipe-Rives I. Selección de materiales. Tendencias actuales y futuras. Monogr Dermatol 2010; 24: 188-95.

  31. Dadzie OE, Mahalingam M, Parada M, El Helou T, Philips T, Bhawan J. Adverse reactions to soft tissue fillers – a review of the histological features. J Cutan Pathol 2008; 35: 536-48.

  32. Parada MB, Michalany NS, Hassun KM, Bagatin E, Talarico S. A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 2005; 4: 345-9.

  33. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 2001; 27: 185-91.

  34. Hamilton RG, Strobos J, Adkinson NF Jr. Immunogenicity studies of cosmetically administered nonanimal-stabilized hya - luronic acid particles. Dermatol Surg 2007; 33 Suppl 2: S176-85.

  35. Pinheiro MV, Bagatin E, Hassun KM, Talarico S. Adverse affect of soft tissue augmentation with hyaluronic acid. J Cosmet Dermatol 2005; 4: 184-6.

  36. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31: 893-7.

  37. Grossman KL. Hyaluronic acid gel fillers: hypersensitivity reactions. Aesthet Surg J 2005: 25: 403-5.

  38. Barbucci R, Lamponi S, Magnani A, Renier D. The influence of molecular weight on the biological activity of heparin like sulphated hyaluronic acids. Biomaterials 1998; 19: 801-6.

  39. Dal Sacco D, Cozzani E, Parody A, Rebora A. Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol 2005; 44: 411-2.

  40. Schanz S, Schipper W, Ulmer A, Rassner G, Fierlbeck G. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002; 146: 928-9.

  41. Pope J Jr, Sternberg P Jr, Mclane NJ, Potts DW, Stulting RD. Mycobacterium chelonae scleral abscess after removal of a scleral buckle. Am J Ophthalmol 1989; 107: 557-8.

  42. Massone C, Horn M, Kerl H, Ambros- Rudolph CM, Brunasso AMG, Cerroni L. Foreign body granuloma due to Matridex injection for cosmetic purposes. Am J Dermatopathol 2009; 31: 197-9.

  43. Moulonguet I, de Goursac V, Plantier F. Granulomatous reaction after injection of a new resorbable filler Novabel. Am J Dermatopathol 2011; 33: 710-11.

  44. Schuller-Petrovi S, Pavlovi MD, Schuller SS, Schuller-Lukic B, Neuhold N. Early granulomatous foreign body reactions to a novel alginate dermal filler: the system’s failure? J Eur Acad Dermatol Venereol 2011; Sep 20 (Epub ahead of print).

  45. Gogolewski S, Jovanovic M, Perren SM, Dilon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrateco- 3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48.

  46. Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L-lactide/glycolide) acid microspheres made by solvent evaporation method. Biomaterials 1989; 10: 557-63.

  47. Goldan O, Garbov-Nardini G, Regev E, Orenstein A, Winkler E. Late-onset infections and granuloma formation after facial polylactic acid (New-Fill) injections in women who are heavy smokers. Plast Recontr Surg 2008; 121: 336e-8.

  48. Azizzadeh B. Late-onset infections and granuloma formation after facial polylactic acid (new-fill) injections in women who are heavy smokers. Plast Reconstr Surg 2009; 124: 316-7.

  49. Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study. J Am Acad Dermatol 2008; 59: 923-33.

  50. Dijkema SJ, van der Lei B, Kibbelaar RE. New-fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg 2005; 115: 76-8.

  51. Lafaurie M, Dolivo M, Porcher R, Rudant J, Madelaine I, Molina JM. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38: 393- 8.

  52. Duffy DM. Complications of fillers. Overview. Dermatol Surg 2005; 31: 1626-33.

  53. Foucar E, Downing DT, Gerber WL. Sclerosing lipogranuloma of the male genitalia containing vitamin E: a comparison with classical “paraffinoma”. J Am Acad Dermatol 1983; 9: 103-10.

  54. Steffens J, Kosharskyy B, Hiebl R, Schönberger B, Röttger P, Loening S. Paraffinoma of the external genitalia after autoinjection of vaseline. Eur Urol 2000; 38: 778-81.

  55. Cohen JL, Keoleian CM, Krull EA. Penile paraffinoma: self-injection with mineral oil. J Am Acad Dermatol 2001; 45: 222-4.

  56. Santos P, Chaveiro A, Nunes G, Fonseca J, Cardoso J. Penile paraffinoma. J Eur Acad Dermatol Venereol 2003; 17: 583-4.

  57. Oertel YC, Johnson FB. Sclerosing lipogranuloma of male genitalia. Arch Pathol Lab Med 1977; 101: 321-6.

  58. Claudy A, Garcier F, Schmitt D. Sclerosing lipogranuloma of the male genitalia: ultrastructural study. Br J Dermatol 1981; 105: 451-5.

  59. López H, Harris K. Ultrasound interactions with free silicone in a tissue-mimicking phantom. J Ultrasound Med 1998; 17: 163–170.

  60. Harris KM, Ganott MA, Shestak KC, Losken HW, Tobon H. Silicone implant rupture: detection with US. Radiology 1993; 187: 761–8.

  61. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulites, ulceration, and migration. Aesthetic Plast Surg 1996; 20: 267-76.

  62. Restrepo CS, Artunduaga M, Carrillo JA, Rivera AL, Ojeda P, Martínez Jiménez S et al. Silicone pulmonary embolism: report of 10 cases and review of the literature. J Comput Assist Tomogr 2009; 33: 233-7.

  63. Krayenbühl BH, Panizzon RG. Silicone granuloma. Dermatology 2000; 200: 360-2.

  64. Mustacchio V, Cabibi D, Minervini MI, Barresi E, Amato S. A diagnostic trap for the dermatopathologist: granulomatous reactions from cutaneous microimplants for cosmetic purposes. J Cutan Pathol 2007; 34: 281-3.

  65. Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 1999; 23: 113-7.

  66. McClelland M, Egbert B, Hanko V, Berg RA, DeLustro F. Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization. Plast Reconstr Surg 1997; 100: 1466-74.

  67. Rosa SC, de Magalhães AV, de Macedo JL. An experimental study of tissuereaction to polymethyl methacrylate (PMMA) microspheres (Artecoll) and dimethylsiloxane (DMS) in the mouse. Am J Dermatopathol 2008; 30: 222-7.

  68. Requena C, Requena L, Sanmartín O, Botella R. Histopathologic findings of granuloma caused by polymethylmethacrylate microspheres. Arch Dermatol 2003; 139: 1505.

  69. Sidwell RU, Dhillon AP, Butler PE, Rustin MH. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol 2004; 29: 630-2.

  70. Vargas-Machuca I, González-Guerra E, Angulo J, Fariña MC, Martín L, Requena L. Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol 2006; 28: 173-7.

  71. Alijotas-Reig J, García Jiménez V, Miró Mur F, Vilardel Tarrés M. Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg 2009; 35 Suppl 1: 360-6.

  72. Xie PB, Shi AP. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesthetic Plast Surg 2002; 26: 375-82.

  73. Patrick T. Polyacrylamide gel in cosmetic procedures: experience with Aquamid. Semin Cutan Med Surg 2004; 23: 233-5.

  74. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33: S168-S175.

  75. Claoue BL, Rabineau P. The polyalkylimide gel. Experience with Bio-Alcamid.TM Semin Cutan Med Surg 2004; 23: 236-40.

  76. Loutfy MR, Raboud JM, Antoniou T, Kovacs C, Shen S, Halpenny R et al. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients. AIDS 2007; 21: 1147-55.

  77. Gómez-de la Fuente E, Alvárez-Fernández JG, Pinedo F, Naz E, Gamo R, Vicente Martín FJ, López Estebaranz JL. Reacción cutánea tras implante con Bio-Alcamid. Actas Dermosifiliogr 2007; 98: 271-5.




2020     |     www.medigraphic.com